HMGA2 and non-small cell lung carcinoma: The plots indicated that higher expression levels of HMGA2 (HR = 1.33; 95% CI = 1.17–1.52; p < 0.05) and E2F7 (HR = 1.75; 95% CI = 1.37–2.23; p < 0.05) were associated with shorter OS in NSCLC patients.